ArticleJTCVS structural and endovascular2025
Midterm outcome of supra-aortic vessels reconstruction: A single-center report.
Article in JTCVS structural and endovascular, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The treatment of complex aortic arch pathologies demands the reconstruction (endovascular or surgical) of 1 or multiple supra-aortic vessels to restore the blood flow of these vessels during thoracic endovascular aortic repair. However, the patency and fate of the endovascular bypass remain unclear. This report compares the midterm outcome of endovascular versus surgical bypass in thoracic endovascular aortic repair. Methods: Between 2007 and 2015, 395 patients underwent thoracic endovascular aortic repair at our institution. Only thoracic endovascular aortic repairs landing proximally at landing zones zero, 1, and 2 were included (244/395). We recorded the type of bypass method used (endovascular or surgical) and the number of supra-aortic vessels bypassed. Results: The median follow-up was 4.1 years. Aortic dissection, thoracic aortic aneurysm, and traumatic aortic injury were the most common indications for thoracic endovascular aortic repair. Endovascular bypass was more commonly used in thoracic endovascular aortic repair landing proximally at zone 1. The 30-day postoperative mortality rate was 11% (25 patients), but it was not different among both methods. Six patients (10.5%) in the endovascular group and 27 patients (16.5%) in the surgical bypass group needed reintervention. The late survival and adverse events were similar. Postoperative stroke occurred in 15 patients (6.8%). Type Ia endoleak was more common after endovascular bypass (17 patients, 36.2%), but this was not statistically significant. Conclusions: In our report, with a tailored approach, the endovascular reconstruction of the supra-aortic vessels was not inferior to the surgical approach and had an acceptable patency rate at mid follow-up with a low rate of complications after surgery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.